Evaluating Fu's Subcutaneous Needling for Carpal Tunnel Syndrome
The Evaluation for Fu's Subcutaneous Needling in Carpal Tunnel Syndrome: a Randomized Controlled Trial.
This study is testing if Fu's Subcutaneous Needling can help people with carpal tunnel syndrome feel better compared to using wrist splints.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 20 Years to 85 Years |
| Sex | All |
| Sponsor | China Medical University Hospital Academic / other |
| Locations | 1 site (Zhubei, Hsinchu County) |
| Trial ID | NCT05627349 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to assess the effectiveness of Fu's Subcutaneous Needling (FSN) in treating carpal tunnel syndrome (CTS). Participants will be divided into two groups, one receiving FSN treatment and the other receiving wrist splinting. The study will evaluate whether FSN can improve symptoms, reduce the cross-sectional area of the median nerve, and influence electrophysiological outcomes in CTS patients. The results will help determine the efficacy of FSN compared to traditional splinting methods.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 20-85 with mild to moderate carpal tunnel syndrome.
Not a fit: Patients with severe carpal tunnel syndrome or those with certain medical conditions such as chronic kidney disease or rheumatoid arthritis may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a new, effective option for patients suffering from carpal tunnel syndrome.
How similar studies have performed: While the specific approach of Fu's Subcutaneous Needling is novel, similar interventions have shown promise in treating musculoskeletal conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female aged 20-85 years old. 2. Meet the diagnosis of mild to moderate carpal tunnel syndrome. 3. If the patient has carpal tunnel syndrome in both hands, choose the side with mild or moderate carpal tunnel syndrome. 4. After being explained, join the trial voluntarily and sign the subject's consent form. Exclusion Criteria: 1. Caused by trauma or mass lesion. 2. Thenar muscle atrophy. 3. Electrophysiological examination revealed severe CTS. 4. Chronic kidney disease, rheumatoid arthritis, abnormal thyroid function, diabetes. 5. Psychiatric history or incapable of cooperating with the investigator. 6. Pregnancy. 7. History of substance abuse or long-term steroid use. 8. History of median nerve surgery. 9. Those who do not sign the consent form.
Where this trial is running
Zhubei, Hsinchu County
- China Medical University Hsinchu Hospital — Zhubei, Hsinchu County, Taiwan (Recruiting)
Study contacts
- Study coordinator: Chih Ying Wu, MD
- Email: zingwu1029@gmail.com
- Phone: +886 4 2205 2121
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.